Search results
Author(s):
Dominik Linz
,
William McIntyre
Added:
1 year ago
In this video from the Arrhythmia Academy’s Journal Club, Dr Dominik Linz (Maastricht University Medical Centre, Maastricht, NL) is joined by Dr William McIntyre (McMaster University, Hamilton, CA) to discuss a paper published in Europace 2022 titled “Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke”…
View more
Colm Hanratty
Job title: Interventional Cardiologist
Author
Stephen Black
Job title: University of Witwatersrand Johannesburg, South Africa, Consultant Vascular Surgeon Professor of Venous Surgery
Author
Author(s):
Jaber Abboud
,
Joachim R Ehrlich
Added:
3 years ago
Implantable cardioverter defibrillators (ICDs) have been used for over 30 years to prevent sudden cardiac death (SCD). The first indications for ICD placement were secondary prevention; later trials demonstrated a primary prevention benefit of ICD therapy in patients at risk of SCD. ICD therapy prolongs life in both patient populations.1 However, the efficacy of an ICD depends on its ability to…
View more
Author(s):
Pok Tin Tang
,
Duc H Do
,
Anthony C Li
,
et al
Added:
3 years ago
Ventricular arrhythmias remain a major contributor to cardiac morbidity and mortality worldwide, despite ongoing research and implementation of novel therapeutic interventions. Modern management of patients with ventricular arrhythmias requires a multidisciplinary team approach, especially in complex presentations with a background of multiple medical comorbidities.1,2 Such teams may include…
View more
Defining LBBB Patterns in CRT
Author(s):
Roderick Tung
,
Gaurav A Upadhyay
Added:
3 years ago
Article
Author(s):
Line Melgaard
Added:
5 years ago
Dr Line Melgaard (Aalborg University, Aalborg, DK) discusses the thromboembolic risk in patients with atrial fibrillation and
valvular heart disease according to the EHRA Type 2 definition.
Filmed on site at EHRA 2019 by Radcliffe Cardiology
Questions:
1. What was the need to evaluate atrial fibrillation patients specifically with valvular heart disease?
2. How was the study set up to…
View more
Author(s):
Pavel Osmancik
Added:
4 years ago
Dr Pavel Osmancik (University Hospital Kralovske Vinohrady, Prague, CZ) discuses 'Long-term follow-up of the PRAGUE-12 study and the five-year outcomes in cardiac surgery patients with atrial fibrillation undergoing concomitant surgical ablation versus no ablation' at HRS 2019.
1. Can you tell us about the Prague-12 Study and why was it initiated?
2. What is the design of the trial?
3. What are…
View more
Nicholas Inston
Author
Author(s):
Jagmeet P Singh
Added:
2 years ago
In this interview, Dr Jagmeet Singh (Massachusetts General Hospital, Harvard Medical School, Boston, MA, US) discusses the Phase I results of the Solve-CRT Study presented at ESC's Heart Rhythm Society event in 2021. This study is a multicenter pivotal trial, investigating the safety of the WiSE CRT System in leadless cardiac resynchronization therapy.
Questions:
1. Could you briefly remind us…
View more